<DOC>
	<DOCNO>NCT01183624</DOCNO>
	<brief_summary>An evaluation safety efficacy herbal patch treat osteoarthritis pain right leave knee .</brief_summary>
	<brief_title>A Controlled Study Herbal Topical Patch Treating Osteoarthritis ( OA ) Knee</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , parallel-group , placebo-controlled study herbal patch subject OA knee pain . The overall objective study evaluate efficacy safety patch relieve OA knee pain .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Male female 40 70 year age Medically clear participate site affiliate physician follow physical History , current diagnosis , OA knee Evidence idiopathic OA least one knee Subject Assessment OA pain target knee 40 75 mm ( 100 mm VAS inclusive ) index knee , WOMAC Pain composite subscale Visit 1 Subject Assessment OA pain nonindex knee ( applicable ) â‰¤ 20mm Subject Global Assessment OA Condition ( 5 pt categorical scale , 1 = good 5 = poor ) grade 35 ( i.e . fair , poor poor ) Evidence idiopathic OA least one knee define American College Rheumatology Classification ( ACR ) OA Knee Grade 1 Grade 4 severity index knee base Kellgren Lawrence radiographic criterion Pain great 20 mm VAS nonindex knee ( either rest movement ) Prior injection arthroscopy study knee within 3 month Crystallineinduced synovitis ( e.g . gout , pseudo gout , nonsteroid arthritis , hydroxyapatite deposit ) , acute inflammatory arthritis , rheumatoid arthritis , psoriatic arthritis , septic arthritis , fibromyalgia , systemic lupus , erythematosus collagen vascular disease type inflammatory arthritis index knee Pain either knee neurological origin An injury surgery body region within prior 6 month lifetime history 3 injuries/surgeries injure body region Signs clinically important active inflammation study knee joint include redness , warmth , and/or large , bulge effusion loss normal contour screen and/or baseline visit Other criterion opinion investigator may jeopardize safety subject study result .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Herbal medicine</keyword>
	<keyword>Topical administration</keyword>
</DOC>